Skip to content

PHARMASAMBRE: what changed

BE 0807.904.486NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€122,705
2024 · €154,062-€31,357
Equity
€532,591
2024 · €574,886-€42,295
Cash
€241,819
2024 · €230,317+€11,502
Balance sheet total
€977,337
2024 · €1.0m-€46,625

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€61,173

    down €61,173 (-16.3%), from €376,146 to €314,973

    of which Other amounts receivable: -€60,472

  • Deferred charges and accrued income +€14,970

    up €14,970 (+449%), from €3,332 to €18,302

  • Cash +€11,502

    up €11,502 (+5.0%), from €230,317 to €241,819

    mainly Net result for the year (+€122,705) and Receivables within one year (+€61,173)

Equity and liabilities
  • Profit (loss) carried forward -€42,295

    down €42,295 (-7.6%), from €554,426 to €512,131

  • Other debts +€14,868

    up €14,868 (+9.9%), from €150,132 to €165,000

  • Debts after one year -€12,887

    down €12,887 (-6.6%), from €194,430 to €181,543

Income statement
  • Write-downs +€30,267

    first reported in 2025, at €30,267

  • Gross operating margin -€11,112

    down €11,112 (-3.0%), from €365,162 to €354,051

  • Taxes -€10,505

    down €10,505 (-34.6%), from €30,360 to €19,856

  • Staff costs +€6,884

    up €6,884 (+4.5%), from €153,072 to €159,956

  • Financial charges -€6,472

    down €6,472 (-69.5%), from €9,310 to €2,838

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €154,062
Gross operating margin -€11,112
Staff costs -€6,884
Depreciation +€417
Write-downs -€30,267
Other operating charges -€529
Financial income +€39
Financial charges +€6,472
Taxes +€10,505
Result 2025 €122,705
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€200,495
Investment -€11,239
Financing -€177,754
Cash 2024 €230,317
Net result for the year +€122,705
Depreciation +€17,718
Stocks and contracts +€5,445
Receivables within one year +€61,173
Deferred charges and accrued income -€14,970
Trade debts -€2,356
Tax, wage and social debts -€4,129
Other debts +€14,868
Accrued charges and deferred income +€42
Investment in fixed assets (net) -€11,239
Debts after one year -€12,887
Current portion of long-term debt +€133
Contributions, distributions and other -€165,000
Cash 2025 €241,819
brings cash intakes cash out
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,023,962 €977,337 -€46,625 -4.6%
Fixed assets 21/28 €208,086 €201,606 -€6,479 -3.1%
Tangible fixed assets 22/27 €208,086 €201,606 -€6,479 -3.1%
Land and buildings 22 €202,245 €188,845 -€13,400 -6.6%
Plant, machinery and equipment 23 €4,453 €1,039 -€3,413 -76.7%
Furniture and vehicles 24 €1,388 €1,722 +€334 +24.1%
Assets under construction and advance payments 27 - €10,000 +€10,000
Current assets 29/58 €815,876 €775,731 -€40,145 -4.9%
Stocks and contracts in progress 3 €206,081 €200,636 -€5,445 -2.6%
Stocks 30/36 €206,081 €200,636 -€5,445 -2.6%
Amounts receivable within one year 40/41 €376,146 €314,973 -€61,173 -16.3%
Trade receivables 40 €177,514 €176,813 -€700 -0.4%
Other amounts receivable 41 €198,632 €138,160 -€60,472 -30.4%
Cash at bank and in hand 54/58 €230,317 €241,819 +€11,502 +5.0%
Deferred charges and accrued income 490/1 €3,332 €18,302 +€14,970 +449%
Total equity and liabilities 10/49 €1,023,962 €977,337 -€46,625 -4.6%
Equity 10/15 €574,886 €532,591 -€42,295 -7.4%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €1,860 €1,860 = 0.0%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Profit (loss) carried forward 14 €554,426 €512,131 -€42,295 -7.6%
Amounts payable 17/49 €449,076 €444,746 -€4,329 -1.0%
Amounts payable after more than one year 17 €194,430 €181,543 -€12,887 -6.6%
Financial debts 170/4 €194,430 €181,543 -€12,887 -6.6%
Amounts payable within one year 42/48 €254,646 €263,162 +€8,516 +3.3%
Current portion of amounts payable after more than one year 42 €12,754 €12,887 +€133 +1.0%
Trade debts 44 €64,106 €61,751 -€2,356 -3.7%
Suppliers 440/4 €64,106 €61,751 -€2,356 -3.7%
Taxes, remuneration and social security 45 €27,653 €23,524 -€4,129 -14.9%
Taxes 450/3 €4,402 - -€4,402
Remuneration and social security 454/9 €23,251 €23,524 +€273 +1.2%
Other amounts payable 47/48 €150,132 €165,000 +€14,868 +9.9%
Accrued charges and deferred income 492/3 - €42 +€42
Remuneration, social security and pensions 62 €153,072 €159,956 +€6,884 +4.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €18,136 €17,718 -€417 -2.3%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - €30,267 +€30,267
Other operating charges 640/8 €222 €750 +€529 +238%
Gross operating margin 9900 €365,162 €354,051 -€11,112 -3.0%
Operating profit (loss) 9901 €193,733 €145,359 -€48,373 -25.0%
Financial income 75/76B - €39 +€39
Recurring financial income 75 - €39 +€39
Financial charges 65/66B €9,310 €2,838 -€6,472 -69.5%
Recurring financial charges 65 €9,310 €2,838 -€6,472 -69.5%
Profit (loss) for the period before taxes 9903 €184,422 €142,560 -€41,862 -22.7%
Income taxes 67/77 €30,360 €19,856 -€10,505 -34.6%
Profit (loss) for the period 9904 €154,062 €122,705 -€31,357 -20.4%
Profit (loss) for the period to be appropriated 9905 €154,062 €122,705 -€31,357 -20.4%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€763,745 to €962,725

Midpoint €846,654 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €532,591
Capitalised earnings €994,900 to €1.4m
Indication €763,745 to €962,725

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€532,591
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€532,591

Capitalised earnings

net result for the year (9904)
2025
€122,705
2024
€154,062
2023
€141,092
2022
€153,071
2021
€119,324
Average result
€139,286
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€994,900 / €1.2m / €1.4m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.